Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESES-LVH
jRCTs071190043Completed
- Sponsor
- Not applicable
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of esaxerenone in hypertension (HTN) and left ventricular hypertrophy (LVH), sponsored by Not applicable. Primary endpoints: Change in early morning sitting home blood pressure from baseline to end of esaxerenone administration and Change in left ventricular mass index from baseline to end of esaxerenone administration. Started Jun 2020; status: completed.
02
Drugs
esaxerenone
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on jRCTs071190043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071190043.